Search by Drug Name or NDC
NDC 00456-1207-30 Namzaric 10; 7 mg/1; mg/1 Details
Namzaric 10; 7 mg/1; mg/1
Namzaric is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Allergan, Inc.. The primary component is DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Donepezil is used to treat dementia (a brain disorder that affects the ability to remember, think clearly, communicate, and perform daily activities and may cause changes in mood and personality) in people who have Alzheimer's disease (AD; a brain disease that slowly destroys the memory and the ability to think, learn, communicate and handle daily activities). Donepezil is in a class of medications called cholinesterase inhibitors. It improves mental function (such as memory, attention, the ability to interact with others, speak, think clearly, and perform regular daily activities) by increasing the amount of a certain naturally occurring substance in the brain. Donepezil may improve the ability to think and remember or slow the loss of these abilities in people who have AD. However, donepezil will not cure AD or prevent the loss of mental abilities at some time in the future.
Related Packages: 00456-1207-30Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Donepezil
Memantine is used to treat the symptoms of Alzheimer's disease (AD; a brain disease that slowly destroys the memory and the ability to think, learn, communicate and handle daily activities). Memantine is in a class of medications called NMDA receptor antagonists. It works by decreasing abnormal activity in the brain. Memantine may improve the ability to think and remember or may slow the loss of these abilities in people who have AD. However, memantine will not cure AD or prevent the loss of these abilities at some time in the future.
Related Packages: 00456-1207-30Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Memantine
Product Information
| NDC | 00456-1207 |
|---|---|
| Product ID | 0456-1207_0b0a604f-041e-43f0-98ad-566f1dcb13df |
| Associated GPIs | 62059902507020 |
| GCN Sequence Number | 076519 |
| GCN Sequence Number Description | memantine HCl/donepezil HCl CAP SPR 24 7 MG-10 MG ORAL |
| HIC3 | H1C |
| HIC3 Description | ALZHEIMER'S THX,NMDA RECEPTOR ANTAG-CHOLINES INHIB |
| GCN | 42126 |
| HICL Sequence Number | 041881 |
| HICL Sequence Number Description | MEMANTINE HCL/DONEPEZIL HCL |
| Brand/Generic | Brand |
| Proprietary Name | Namzaric |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | memantine hydrochloride and donepezil hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 10; 7 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE |
| Labeler Name | Allergan, Inc. |
| Pharmaceutical Class | Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA], N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA206439 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00456-1207-30 (00456120730)
| NDC Package Code | 0456-1207-30 |
|---|---|
| Billing NDC | 00456120730 |
| Package | 30 CAPSULE in 1 BOTTLE (0456-1207-30) |
| Marketing Start Date | 2016-07-18 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 18.9034 |
| Pricing Unit | EA |
| Effective Date | 2024-01-02 |
| NDC Description | NAMZARIC 7 MG-10 MG CAPSULE |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |